Drug-Eluting Stents Market Overview: Innovation, Investment Trends, and Competitive Landscape - Boston Scientific Corp., Abbott Laboratories, Medtronic Plc

The Global Drug Eluting Stents Market reached USD 6.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 10.2 billion by 2031. The global drug eluting stents market is expected to exhibit a CAGR of 6.4% during the forecast period (2024-2031)

The Drug Eluting Stents Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/drug-eluting-stents-market?kb

Drug Eluting Stents Market Overview

Drug-Eluting Stents (DES) are small mesh-like tubes placed in narrowed or blocked arteries during angioplasty. These stents are coated with medication that slowly releases over time to prevent the artery from becoming blocked again (restenosis).

Research Methodology:

The global Drug Eluting Stents Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Drug Eluting Stents Market:

By Coating: Polymer-based coating stents (Non-biodegradable polymer, Biodegradable polymer), Polymer-free coating stents

By Application: Coronary Artery Diseases, Peripheral Artery Disease

By End-user: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/drug-eluting-stents-market?kb

List of the Key Players in the Drug Eluting Stents Market:

Boston Scientific Corp., Abbott Laboratories, Medtronic Plc, Biotronik Inc., Johnson & Johnson, MicroPort Scientific Corporation, Cook Medical Inc., Stentys S.A., Biosensors International Group, and Terumo Corp., among others.

Industry Development:

In May 2023, CoSo Health announced a distribution agreement to bring Medinol's EluNIR a next-generation, thin-strut drug-eluting stent (DES) to the U.S. market. Medinol is a global leader in innovative implantable medical devices, while U.S. Endovascular handles the nationwide distribution of peripheral and coronary products.

Regional Analysis for Drug Eluting Stents Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Drug Eluting Stents market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Drug Eluting Stents industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Drug Eluting Stents market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.